<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02337244</url>
  </required_header>
  <id_info>
    <org_study_id>CSE2013-07K</org_study_id>
    <nct_id>NCT02337244</nct_id>
  </id_info>
  <brief_title>Zimmer POLAR Persona - TKA (EMEA Study)</brief_title>
  <official_title>Persona Outcomes Led Assessment Research in Total Knee Arthroplasty (POLAR - TKA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer, GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to obtain implant survivorship and clinical outcomes&#xD;
      data for commercially available Persona knee implants used in primary total knee&#xD;
      arthroplasty. The assessment will include:&#xD;
&#xD;
        1. Implant survivorship based on removal of a study device.&#xD;
&#xD;
        2. Safety based on incidence and frequency of adverse events.&#xD;
&#xD;
        3. Clinical performance measured by overall pain and function, quality of life data,&#xD;
           radiographic parameters and survivorship.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multicenter, non-controlled study of the commercially available&#xD;
      Persona knee implants. The study will require each site to obtain Ethics approval prior to&#xD;
      study enrollment. All potential study subjects will be required to participate in the&#xD;
      Informed Consent Process.&#xD;
&#xD;
      Study subjects will undergo preoperative clinical evaluations prior to their total knee&#xD;
      arthroplasty. The post-operative clinical and radiographic evaluations will be conducted at 5&#xD;
      days to 6 weeks, 3 to 6 months, 1 year, 2, 3, 4, and 5 years after implantation. The hospital&#xD;
      CHU Clermont-Ferrand, France with PI Prof. Boisgard will conduct additional 7 (voluntary) and&#xD;
      10 years (standard of care) follow-up visits.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Anticipated">November 2027</completion_date>
  <primary_completion_date type="Anticipated">November 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Kaplan-Meier Implant Survivorship</measure>
    <time_frame>5 years</time_frame>
    <description>Kaplan-Meier survivorship at 5 years with revision of any implant component, for any reason, as endpoint.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>'Knee injury and Osteoarthritis Outcome Score' (KOOS) subscale scores.</measure>
    <time_frame>5 years</time_frame>
    <description>The scores related to the five KOOS subscales calculated at different time points until 5 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>'Forgotten Joint Score' (FJS-12)</measure>
    <time_frame>5 years</time_frame>
    <description>The score related to the FJS-12 patient-reported questionaire calculated at different time points until 5 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxford Knee Score (OKS)</measure>
    <time_frame>5 years</time_frame>
    <description>The score related to the OKS patient-reported questionaire calculated at different time points until 5 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol (EQ)-5D-3L score and EQ 'Visual Analog Scale' (VAS)</measure>
    <time_frame>5 years</time_frame>
    <description>The scores related to the EQ-5D-3L questionnaire and the EQ-VAS calculated at different time points until 5 years.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Severe Knee Pain</condition>
  <condition>Severe Knee Disability</condition>
  <condition>Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Traumatic Arthritis</condition>
  <condition>Polyarthritis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zimmer Persona Total Knee System</intervention_name>
    <description>No Intervention</description>
    <other_name>Primary Knee Replacement</other_name>
    <other_name>Total Knee Arthroplasty</other_name>
    <other_name>Total Knee Replacement</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary total knee arthroplasty subjects that receive the Zimmer Persona Total Knee System.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient 18-75 years of age, inclusive.&#xD;
&#xD;
          -  Patient qualifies for primary total knee arthroplasty based on physical exam and&#xD;
             medical history, including diagnosis of severe knee pain and disability due to at&#xD;
             least one of the following:&#xD;
&#xD;
               -  rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis;&#xD;
&#xD;
               -  collagen disorders and/or avascular necrosis of the femoral condyle;&#xD;
&#xD;
               -  post-traumatic loss of joint configuration, particularly when there is&#xD;
                  patellofemoral erosion, dysfunction or prior patellectomy;&#xD;
&#xD;
               -  moderate valgus, varus, or flexion deformities;&#xD;
&#xD;
               -  the salvage of previously failed surgical attempts that did not include partial&#xD;
                  or total knee arthroplasty of the ipsilateral knee.&#xD;
&#xD;
          -  Patient is willing and able to complete scheduled study procedures and follow-up&#xD;
             evaluations.&#xD;
&#xD;
          -  Independent of study participation, patient is a candidate for commercially available&#xD;
             Zimmer Persona knee implants implanted in accordance with product labeling.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is currently participating in any other surgical intervention studies or pain&#xD;
             management studies.&#xD;
&#xD;
          -  Previous history of infection in the affected joint and/or other local/systemic&#xD;
             infection that may affect the prosthetic joint.&#xD;
&#xD;
          -  Insufficient bone stock on femoral or tibial surfaces.&#xD;
&#xD;
          -  Skeletal immaturity.&#xD;
&#xD;
          -  Neuropathic arthropathy.&#xD;
&#xD;
          -  Osteoporosis or any loss of musculature or neuromuscular disease that compromises the&#xD;
             affected limb.&#xD;
&#xD;
          -  Stable, painless arthrodesis in a satisfactory functional position.&#xD;
&#xD;
          -  Severe instability secondary to the absence of collateral ligament integrity.&#xD;
&#xD;
          -  Rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent&#xD;
             breakdown of the skin.&#xD;
&#xD;
          -  Patient has a known or suspected sensitivity or allergy to one or more of the implant&#xD;
             materials.&#xD;
&#xD;
          -  Patient is pregnant or considered a member of a protected population (e.g., prisoner,&#xD;
             mentally incompetent, etc.).&#xD;
&#xD;
          -  Patient has previously received partial or total knee arthroplasty for the ipsilateral&#xD;
             knee.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Dominkus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopädisches Spital Speising, Wien, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hendrik Verburg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stichting Research Orthopedie &amp; Reinier de Graaf Groep, Delf, Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicholas London, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harrogate and District NHS, Harrogate, England</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stéphane Boisgard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Clermont-Ferrand, Clermont-Ferrand, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François Canovas, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Lapeyronie, Montpellier</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pere Torner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Parc Tauli, Sabadell</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon Clarke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Golden Jubilee National Hospital, Clydebank</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Deehan, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Freeman Hospital, Newcastle</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karl Dieter Heller, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>HEH Braunschweig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fritz Thorey, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atos Klinik Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Martinez Delgado, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Miguel Servet Zaragoza</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hermant Pandit, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leeds</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wing To</last_name>
    <email>wing.to@zimmerbiomet.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emilie Rohmer</last_name>
    <email>emilie.rohmer@zimmerbiomet.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Orthopädisches Spital Speising</name>
      <address>
        <city>Wien</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier régional Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34980</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>HEH Braunschweig</name>
      <address>
        <city>Braunschweig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Atos Klinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stichting Research Orthopedie &amp; Reinier de Graaf Groep</name>
      <address>
        <city>Delft</city>
        <zip>2612</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Leeds</name>
      <address>
        <city>Leeds</city>
        <state>Leeds/UK</state>
        <zip>LS2 9JT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hermant Pandit, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Hermant Pandit, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Clydebank</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Kellett</last_name>
      <email>Catherine.Kellett@gjnh.scot.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jon MD Clarke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harrogate and District NHS</name>
      <address>
        <city>Harrogate</city>
        <zip>HG2 7SX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Newcastle Upon Tyne Hospitals</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 6, 2015</study_first_submitted>
  <study_first_submitted_qc>January 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Rheumatoid arthritis</keyword>
  <keyword>Traumatic arthritis</keyword>
  <keyword>Polyarthritis</keyword>
  <keyword>Total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

